Schonfeld Strategic Advisors LLC Terns Pharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 2,268,428 shares of TERN stock, worth $17 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
2,268,428
Previous 1,195,794
89.7%
Holding current value
$17 Million
Previous $7.84 Million
96.93%
% of portfolio
0.11%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding TERN
# of Institutions
133Shares Held
63.4MCall Options Held
413KPut Options Held
106K-
Orbimed Advisors LLC San Diego, CA7.62MShares$57.1 Million1.25% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.18MShares$46.4 Million6.22% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.1MShares$45.8 Million1.36% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.95MShares$37.1 Million3.41% of portfolio
-
Black Rock Inc. New York, NY4.12MShares$30.9 Million0.0% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $282M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...